Imaging of CAR T-Cells in Cancer Patients: Paving the Way to Treatment Monitoring and Outcome Prediction.
作者信息
Krebs Simone, Ponomarev Vladimir, Slovin Susan, Schöder Heiko
机构信息
Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Radiochemistry and Molecular Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
出版信息
J Nucl Med. 2019 Jul;60(7):879-881. doi: 10.2967/jnumed.119.227561. Epub 2019 May 3.
Abstract
摘要
相似文献
1
Imaging of CAR T-Cells in Cancer Patients: Paving the Way to Treatment Monitoring and Outcome Prediction.
J Nucl Med. 2019 Jul;60(7):879-881. doi: 10.2967/jnumed.119.227561. Epub 2019 May 3.
2
Chimeric Antigen Receptor (CAR) T-Cell Therapy.
JAMA Oncol. 2017 Nov 1;3(11):1595. doi: 10.1001/jamaoncol.2017.2989.
3
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy.
J Hematol Oncol. 2019 Nov 29;12(1):128. doi: 10.1186/s13045-019-0813-7.
4
Engineering CAR-T Cells for Next-Generation Cancer Therapy.
Cancer Cell. 2020 Oct 12;38(4):473-488. doi: 10.1016/j.ccell.2020.07.005. Epub 2020 Jul 30.
5
Companion vaccines for CAR T-cell therapy: applying basic immunology to enhance therapeutic efficacy.
Future Med Chem. 2020 Aug;12(15):1359-1362. doi: 10.4155/fmc-2020-0081. Epub 2020 Jun 29.
6
Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspective.
Immunotherapy. 2018 Mar;10(3):221-234. doi: 10.2217/imt-2017-0133.
7
CAR T-cell therapy for solid tumours.
Lancet Oncol. 2021 Jul;22(7):893. doi: 10.1016/S1470-2045(21)00353-3.
8
Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring.
Theranostics. 2021 May 3;11(14):6800-6817. doi: 10.7150/thno.56989. eCollection 2021.
9
Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward.
Front Immunol. 2020 Apr 22;11:702. doi: 10.3389/fimmu.2020.00702. eCollection 2020.
10
Cas13d-mediated gene knockdown in CAR T cells: towards off-the-shelf cancer treatment.
Signal Transduct Target Ther. 2024 Apr 26;9(1):113. doi: 10.1038/s41392-024-01830-3.
引用本文的文献
1
CAR-T cell therapy in brain malignancies: obstacles in the face of cellular trafficking and persistence.
Front Immunol. 2025 Jun 19;16:1596499. doi: 10.3389/fimmu.2025.1596499. eCollection 2025.
2
Development of a DNA Aptamer-Based Approach to Noninvasively Image CAR-T Cells In Vivo and Traceless Enrichment In Vitro.
Adv Sci (Weinh). 2025 Jul;12(28):e2506746. doi: 10.1002/advs.202506746. Epub 2025 May 11.
3
A Novel Luciferase-Based Reporter Gene Technology for Simultaneous Optical and Radionuclide Imaging of Cells.
Int J Mol Sci. 2024 Jul 27;25(15):8206. doi: 10.3390/ijms25158206.
4
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications.
Theranostics. 2023 Oct 8;13(15):5469-5482. doi: 10.7150/thno.87489. eCollection 2023.
5
Probing immune infiltration dynamics in cancer by in vivo imaging.
Curr Opin Chem Biol. 2022 Apr;67:102117. doi: 10.1016/j.cbpa.2022.102117. Epub 2022 Feb 23.
6
Highly aminated iron oxide nanoworms for simultaneous manufacturing and labeling of chimeric antigen receptor T cells.
J Magn Magn Mater. 2022 Jan 1;541. doi: 10.1016/j.jmmm.2021.168480. Epub 2021 Aug 29.
7
Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma.
J Immunother Cancer. 2021 Aug;9(8). doi: 10.1136/jitc-2020-002303.
8
Pharmacokinetic and pharmacodynamic studies of CD19 CAR T cell in human leukaemic xenograft models with dual-modality imaging.
J Cell Mol Med. 2021 Aug;25(15):7451-7461. doi: 10.1111/jcmm.16776. Epub 2021 Jul 9.
9
Current and Future Role of Medical Imaging in Guiding the Management of Patients With Relapsed and Refractory Non-Hodgkin Lymphoma Treated With CAR T-Cell Therapy.
Front Oncol. 2021 May 28;11:664688. doi: 10.3389/fonc.2021.664688. eCollection 2021.
10
Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy.
J Nanobiotechnology. 2021 Jun 10;19(1):175. doi: 10.1186/s12951-021-00924-2.
本文引用的文献
1
Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer.
Nat Med. 2018 Dec;24(12):1852-1858. doi: 10.1038/s41591-018-0255-8. Epub 2018 Nov 26.
2
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo.
Nat Biotechnol. 2018 Oct;36(9):847-856. doi: 10.1038/nbt.4195. Epub 2018 Aug 13.
3
Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot study.
Oncotarget. 2018 Jul 13;9(54):30268-30278. doi: 10.18632/oncotarget.25666.
4
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes.
J Nucl Med. 2018 Dec;59(12):1894-1900. doi: 10.2967/jnumed.118.208041. Epub 2018 Jun 14.
5
Imaging T Cell Dynamics and Function Using PET and Human Nuclear Reporter Genes.
Methods Mol Biol. 2018;1790:165-180. doi: 10.1007/978-1-4939-7860-1_13.
6
Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.
Nat Commun. 2018 Mar 14;9(1):1081. doi: 10.1038/s41467-018-03524-1.
7
A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant.
Cancer Res. 2017 Jun 1;77(11):2893-2902. doi: 10.1158/0008-5472.CAN-16-2953.
8
Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective.
Mol Ther. 2017 May 3;25(5):1117-1124. doi: 10.1016/j.ymthe.2017.03.034. Epub 2017 Apr 26.
9
Advancing Immune and Cell-Based Therapies Through Imaging.
Mol Imaging Biol. 2017 Jun;19(3):379-384. doi: 10.1007/s11307-017-1069-7.
10
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.
Nature. 2017 Mar 2;543(7643):113-117. doi: 10.1038/nature21405. Epub 2017 Feb 22.
Zotero 插件